At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Clareondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Binocular Visual Acuity and Refractive Stability in the Alcon Clareon Intraocular Lens
In Brief
An observational study evaluating Clareon for Cataract. Completed, enrolled 31 participants across 1 site.
Detailed Summary
The objective is to evaluate refractive stability (spherical equivalent change ≤ 0.50D from 1-month to 3-months).
Study Details
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJun 2021
Enrollment StartJul 2021
Primary CompletionJul 2022
TodayJul 2026
First PostedJun 23, 2021
Enrollment StartJul 2, 2021
Primary CompletionJul 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.0 years ago
Interventions
Clareondevice
Clareon monofocal intraocular lens (IOL)